Commission Implementing Regulation (EU) 2017/841 of 17 May 2017 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, Ampelomyces quisqualis strain: aq 10, benalaxyl, bentazone, bifenazate, bromoxynil, carfentrazone ethyl, chlorpropham, cyazofamid, desmedipham, diquat, DPX KE 459 (flupyrsulfuron-methyl), etoxazole, famoxadone, fenamidone, flumioxazine, foramsulfuron, Gliocladium catenulatum strain: j1446, imazamox, imazosulfuron, isoxaflutole, laminarin, metalaxyl-m, methoxyfenozide, milbemectin, oxasulfuron, pendimethalin, phenmedipham, pymetrozine, s-metolachlor, and trifloxystrobin (Text with EEA relevance. )
Annex 1ANNEX
In force · version of May 18, 2017
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:
(1) In the sixth column, expiration of approval, of row 11 Bentazone, the date is replaced by ‘30 June 2018’;
(2) In the sixth column, expiration of approval, of row 15 Diquat, the date is replaced by ‘30 June 2018’;
(3) In the sixth column, expiration of approval, of row 19 DPX KE 459 (flupyrsulfuron-methyl), the date is replaced by ‘30 June 2018’;
(4) In the sixth column, expiration of approval, of row 23 Pymetrozine, the date is replaced by ‘30 June 2018’;
(5) In the sixth column, expiration of approval, of row 35 Famoxadone, the date is replaced by ‘30 June 2018’;
(6) In the sixth column, expiration of approval, of row 37 Metalaxyl-M, the date is replaced by ‘30 June 2018’;
(7) In the sixth column, expiration of approval, of row 39 Flumioxazine, the date is replaced by ‘30 June 2018’;
(8) In the sixth column, expiration of approval, of row 41 Imazamox, the date is replaced by ‘31 July 2018’;
(9) In the sixth column, expiration of approval, of row 42 Oxasulfuron, the date is replaced by ‘31 July 2018’;
(10) In the sixth column, expiration of approval, of row 44 Foramsulfuron, the date is replaced by ‘31 July 2018’;
(11) In the sixth column, expiration of approval, of row 46 Cyazofamid, the date is replaced by ‘31 July 2018’;
(12) In the sixth column, expiration of approval, of row 53 Pendimethalin, the date is replaced by ‘31 July 2018’;
(13) In the sixth column, expiration of approval, of row 59 Trifloxystrobin, the date is replaced by ‘31 July 2018’;
(14) In the sixth column, expiration of approval, of row 60 Carfentrazone ethyl, the date is replaced by ‘31 July 2018’;
(15) In the sixth column, expiration of approval, of row 62 Fenamidone, the date is replaced by ‘31 July 2018’;
(16) In the sixth column, expiration of approval, of row 63 Isoxaflutole, the date is replaced by ‘31 July 2018’;
(17) In the sixth column, expiration of approval, of row 78 Chlorpropham, the date is replaced by ‘31 July 2018’;
(18) In the sixth column, expiration of approval, of row 83 Alpha-cypermethrin, the date is replaced by ‘31 July 2018’;
(19) In the sixth column, expiration of approval, of row 84 Benalaxyl, the date is replaced by ‘31 July 2018’;
(20) In the sixth column, expiration of approval, of row 85 Bromoxynil, the date is replaced by ‘31 July 2018’;
(21) In the sixth column, expiration of approval, of row 86 Desmedipham, the date is replaced by ‘31 July 2018’;
(22) In the sixth column, expiration of approval, of row 88 Phenmedipham, the date is replaced by ‘31 July 2018’;
(23) In the sixth column, expiration of approval, of row 93 Ampelomyces quisqualis Strain: AQ 10, the date is replaced by ‘31 July 2018’;
(24) In the sixth column, expiration of approval, of row 95 Laminarin, the date is replaced by ‘31 July 2018’;
(25) In the sixth column, expiration of approval, of row 96 Methoxyfenozide, the date is replaced by ‘31 July 2018’;
(26) In the sixth column, expiration of approval, of row 97 S-metolachlor, the date is replaced by ‘31 July 2018’;
(27) In the sixth column, expiration of approval, of row 98 Gliocladium catenulatum Strain: J1446, the date is replaced by ‘31 July 2018’;
(28) In the sixth column, expiration of approval, of row 99 Etoxazole, the date is replaced by ‘31 July 2018’;
(29) In the sixth column, expiration of approval, of row 109 Bifenazate, the date is replaced by ‘31 July 2018’;
(30) In the sixth column, expiration of approval, of row 110 Milbemectin, the date is replaced by ‘31 July 2018’.